Diabetes Mellitus and Pregnancy : Knowledge Assessment
DMPKA
Evaluation of Knowledge About Contraception and Pregnancy Planning Among Type 1 and Type 2 Diabetes Women
1 other identifier
observational
122
1 country
1
Brief Summary
Diabetes, a chronic and frequent disease, is a risk factor of pregnancy complications such as preeclampsia, congenital malformations and macrosomia. Preconception care is all methods to assess the best prognostic for a diabetic pregnancy. Among these methods, contraception is very important to plan the pregnancy on a chosen moment. The content of the preconception care is well established. However, information of diabetic women concerning contraception and giabetic pregnancy has been little studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2020
CompletedFirst Submitted
Initial submission to the registry
April 15, 2020
CompletedFirst Posted
Study publicly available on registry
April 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedJune 16, 2022
June 1, 2022
5 months
April 15, 2020
June 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk of unplanned pregnancy
Knowledge concerning the risk of unplanned pregnancy in diabete women
Day 0
Study Arms (1)
Diabetic patients
Women between 18 and 40 years old with type 1 and type 2 diabetes
Interventions
Eligibility Criteria
Women between 18 and 40 years old, consulting in diabetology department of Reims Universitary Hospital and Charleville Mézières General Hospital
You may qualify if:
- Patients Aged between 18 and 40 years old
- With type 1 or type 2 diabetes mellitus
- Consulting in the department of diabetology in Reims and Charleville Mezieres hospitals
- Accepting to participate in the study
You may not qualify if:
- Patients With secondary diabetes (endocrine, pancreatic or genetical origin)
- With postmenopausal status
- Without capacity to have a pregnancy (uterine aplasia, hysterectomy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Damien JOLLY
Reims, France
Related Publications (1)
Feutry L, Barbe C, Marquet-Dupont A, Fevre A, Lukas-Croisier C, Vitellius G, Delemer B, Barraud S. Contraception use and knowledge related to pregnancy in diabetic women. Ann Endocrinol (Paris). 2022 Apr;83(2):88-94. doi: 10.1016/j.ando.2022.01.007. Epub 2022 Feb 7.
PMID: 35143750DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2020
First Posted
April 17, 2020
Study Start
March 12, 2020
Primary Completion
July 31, 2020
Study Completion
September 30, 2020
Last Updated
June 16, 2022
Record last verified: 2022-06